SANDOSTATIN

Drug Novartis Pharmaceuticals Corporation
Total Payments
$1.1M
Transactions
2,127
Doctors
1,441
Companies
3

Payment Trends by Year

Year Amount Transactions Doctors
2024 $171,525 33 7
2023 $246,242 60 7
2022 $267,006 24 2
2021 $290,692 35 25
2020 $304.61 20 17
2019 $35,355 1,834 1,354
2018 $22,214 63 46
2017 $22,762 58 42

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $804,215 38 76.1%
Travel and Lodging $190,219 92 18.0%
Food and Beverage $31,754 1,962 3.0%
Unspecified $17,200 23 1.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,593 11 0.9%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,120 1 0.3%

Payments by Type

General
$1.0M
2,104 transactions
Research
$17,200
23 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
RESEARCH RELATED PUBLICATION SUPPORT NOVARTIS PHARMACEUTICALS CORPORATION $10,859 5
RESEARCH RELATED PUBLICATIONS SUPPORT NOVARTIS PHARMACEUTICALS CORPORATION $6,341 1

Top Doctors Receiving Payments for SANDOSTATIN

Doctor Specialty Location Total Records
, APRN Adult Health Manchester, CT $348,516 40
, MSN,FNPC Nurse Practitioner Lafayette, LA $260,690 8
, APRN Women's Health Omaha, NE $106,523 21
, APRN Nurse Practitioner Largo, FL $82,091 23
, APRN Family Cranbury, NJ $57,577 14
, FNP Nurse Practitioner East Syracuse, NY $54,984 3
, RN, CPNP Pediatrics Kansas City, MO $45,929 11
, NP Women's Health Minneapolis, MN $10,113 3
, M.D Endocrinology, Diabetes & Metabolism Los Angeles, CA $9,982 1
, MD Medical Oncology Tampa, FL $9,008 8
, CNS Oncology Columbus, OH $8,606 1
, MD Medical Oncology Houston, TX $8,178 14
, MD Gastroenterology New York, NY $6,341 5
, MD Internal Medicine Boston, MA $5,915 1
, M.D Medical Oncology Philadelphia, PA $3,676 2
, M.D Hematology Baltimore, MD $1,975 2
, M.D Hematology & Oncology Durham, NC $722.00 2
, MD Internal Medicine San Francisco, CA $670.30 1
, MD Internal Medicine Boston, MA $670.30 1
, MD Internal Medicine Houston, TX $670.30 1
, MD Medical Oncology Chicago, IL $670.30 1
, MD Internal Medicine Boston, MA $520.00 3
, MD Endocrinology, Diabetes & Metabolism Portland, OR $422.00 1
, MD Medical Oncology Port Charlotte, FL $202.82 2
, DO Hematology & Oncology Port Charlotte, FL $188.52 1

About SANDOSTATIN

SANDOSTATIN is a drug associated with $1.1M in payments to 1,441 healthcare providers, recorded across 2,127 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharmaceuticals Corporation.

Payment data is available from 2017 to 2024. In 2024, $171,525 was paid across 33 transactions to 7 doctors.

The most common payment nature for SANDOSTATIN is "Consulting Fee" ($804,215, 76.1% of total).

SANDOSTATIN is associated with 2 research studies, including "RESEARCH RELATED PUBLICATION SUPPORT" ($10,859).